TER.NASDAQTeradyne, INC

Form 4: Teradyne CEO Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Teradyne's President and CEO, Gregory Stephen Smith, reported the sale of 554 shares of common stock at $106 per share under a pre-arranged plan.

Summary

  • Gregory Stephen Smith, President and CEO, and Director of Teradyne, Inc. (TER), sold 554 shares of common stock.
  • The transaction occurred on August 12, 2025, at a price of $106 per share.
  • The sale was executed under a Rule 10b5-1 trading plan adopted on February 4, 2025.
  • Following the sale, Mr. Smith directly beneficially owns 96,992.995 shares of Teradyne common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-arranged Rule 10b5-1 trading plan, which is a common practice for executives and does not typically indicate a change in company fundamentals or outlook.

Positives

  • The sale was conducted under a Rule 10b5-1 trading plan, demonstrating adherence to regulatory best practices for insider transactions and pre-planned diversification.

Negatives

  • The sale of shares by a key executive, even under a pre-arranged plan, could be misinterpreted by some market participants as a signal of reduced confidence, although this is typically not the case for routine 10b5-1 sales.

Future Outlook

No forward-looking statements or guidance are provided in this insider transaction report.

Industry Context

This Form 4 filing reports a routine insider transaction for Teradyne, a leading supplier of automated test equipment. Insider sales, particularly those executed under Rule 10b5-1 plans, are common across all industries as executives manage personal financial planning and diversification, and do not typically reflect specific industry trends.

Stakeholder Impact

  • The impact on shareholders is minimal as this is a routine, pre-planned insider sale of a relatively small number of shares, not indicative of a change in company fundamentals.

Key Dates

DateDescription
02/04/2025Date Rule 10b5-1 sales plan was adopted by Reporting Person.
08/12/2025Date of common stock transaction (sale of 554 shares).
08/14/2025Date Form 4 was signed and filed.

Recommendation

hold

The reported insider sale by Teradyne's CEO is a routine transaction executed under a pre-arranged Rule 10b5-1 trading plan. This type of sale is typically for personal financial planning or diversification and does not reflect a change in the company's fundamental outlook or performance. Therefore, it does not provide new information that would alter an existing investment thesis, warranting a 'hold' recommendation.

Keywords

Teradyne, TER, Insider Trading, Form 4, Stock Sale, CEO, Gregory Stephen Smith, 10b5-1 Plan, Semiconductor Equipment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.